Original language | English (US) |
---|---|
Pages (from-to) | E221117 |
Journal | JAMA Network Open |
DOIs | |
State | Accepted/In press - 2022 |
Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019
S. M.Qasim Hussaini, Arjun Gupta, Kelly E. Anderson, Jeromie M. Ballreich, Lauren Hersch Nicholas, G. Caleb Alexander
Research output: Contribution to journal › Letter › peer-review